It seemed like the indexes were largely stuck for most of the trading day following the July CPI reading that was very anticipated, but elicited little reaction as it came in as expected. The Nasdaq was flat, the S&P 500…
Read in context ›Teva Pharmaceutical Stock (TEVA)
Track Teva Pharmaceutical stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
TEVA
Teva Pharmaceutical
healthcare
$33.19
▲ +15.49 (+87.17%) past year
Market Cap
$39.62B
P/E Ratio
25.5x
1Y Return
+87.17%
EPS (TTM)
$1.35
Read the latest TheStreet Pro articles mentioning Teva Pharmaceutical, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
9 articlesDaily Diary Mentions
1 mentionWrapping Things Up With Some Odds and Ends